Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2023-12-03 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
关于召开2023年第四次临时股东大会通知公告（提供网络投票）
Regulatory Filings Classification · 95% confidence The document is a notice announcing the convening of the 2023 fourth extraordinary general meeting of shareholders (临时股东大会通知公告). It details the meeting date, voting methods, agenda items to be discussed, and procedural information for shareholders. It does not contain financial statements or detailed financial analysis. The document is relatively short (3301 characters) and serves as an announcement for a shareholder meeting rather than a report or results announcement. Therefore, it fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting itself and not the voting results or proxy materials, it is closest to a Regulatory Filing (RNS) as a general regulatory announcement. Given the specificity of the categories, and that it is a meeting notice (not voting results or proxy solicitation), the best classification is Regulatory Filings (RNS).
2023-12-03 Chinese
关于购买公司和董监高责任险的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's decision to purchase liability insurance for the company and its directors, supervisors, and senior management. It includes details about the insurance plan, opinions from independent directors and the supervisory board, and references to board meeting resolutions. The document is a formal announcement of a corporate governance and risk management action, not a financial report, earnings release, or regulatory filing about financial results. It does not contain financial statements or detailed financial data. It is also not a report publication announcement or certification. The content fits best under a regulatory announcement category related to governance and risk management but does not match the specific Governance Information (CGR) category, which typically details internal rules and governance practices. Instead, it is a general regulatory announcement about an insurance purchase decision by the board, which fits the Regulatory Filings (RNS) category as a fallback for miscellaneous filings that do not fit other categories.
2023-12-03 Chinese
第四届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 21st meeting of the 4th Board of Directors of Yunnan Shengwu Gu Pharmaceutical Co., Ltd. It details meeting attendance, agenda items, voting results, and mentions that some matters will be submitted to the shareholders' meeting. The content focuses on board decisions such as share cancellation, amendments to the company charter, purchase of directors and officers liability insurance, and convening a shareholders meeting. There is no financial data, earnings information, or detailed report content. The document is not a full report but an official announcement of board meeting resolutions. Therefore, it fits best under Board/Management Information (MANG). The document length is 2232 characters, which is relatively short and consistent with an announcement rather than a full report.
2023-12-03 Chinese
关于控股股东所持公司部分股份被司法拍卖的进展公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the judicial auction of shares held by the company's controlling shareholder. It details the progress and outcome of the auction, the impact on the company, and future steps. There are no financial statements, management discussions, or detailed financial data. The document is an update on a legal/ownership event rather than a financial report or regulatory certification. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-11-28 Chinese
关于控股股东、实际控制人被限制高消费的公告
Legal Proceedings Report Classification · 95% confidence The document is an official announcement from a company regarding a legal restriction imposed on its controlling shareholder and actual controller, specifically a consumption restriction order issued by a court. It details the nature of the restriction, the parties involved, and the impact on the company. There are no financial statements, earnings data, or management discussions typical of financial reports. The document is a legal and regulatory announcement about a court order affecting key shareholders, which fits the category of Legal Proceedings Report (LTR). The document length is short and focused on legal matters, not a report or announcement of a report publication.
2023-11-26 Chinese
2023年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2023 third extraordinary shareholders' meeting of Yunnan Shengwu Gu Pharmaceutical Co., Ltd. It includes information about the meeting's convening, attendance, agenda items, voting results, and legal opinions confirming the legality and validity of the meeting and its resolutions. The content focuses on shareholder voting outcomes and procedural details rather than financial performance or management reports. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2482 characters, which is consistent with a detailed voting results announcement rather than a brief notice or a full report. Therefore, the correct classification is DVA with high confidence.
2023-11-15 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.